ECP 2022 Final Programme

Monday, 5 Sept 169 ECP 2022 Basel 002 Pathologist account of Digital Pathology in practice, and real-world experience with Paige Prostate Catarina Eloy, Portugal 003 Study Review: Dive into study design, results, and end-user feedback Gareth Byron, United Kingdom BRS-03 Industry Symposium 07:15–08:15 Shanghai Process optimization for a digital pathology workflow with artificial intelligence (Visiopharm) Chair: Martin Kristensson, Denmark 001 Welcome and introduction Martin Kristensson, Denmark 002 Experiences from digitizing the pathology lab of UK Augsburg Ralf Huss, Germany 003 Overview of clinical offering Martin Kristensson, Denmark 004 Q&A Martin Kristensson, Denmark LS-07 Industry Symposium 13:00–14:30 Singapore Connecting Patients to Precision Oncology – the key role of NGS (Thermo Fisher Scientific, Eli Lilly, Bayer Pharma) Chairs: Lukas Bubendorf, Switzerland Nicola Normanno, Italy 001 13:00–13:05 Welcome and Introduction Lukas Bubendorf, Switzerland Nicola Normanno, Italy 002 13:05–13:17 Rapidly Evolving Biomarker Landscape – Tools to Keep Pace Lukas Bubendorf, Switzerland 003 13:17–13:29 Improving cancer care with NGS biomarker testing Paul Hofman, France 004 13:29–13:45 Panel Talk: Clinical Case Presentation and Discussion All 005 13:45–14:05 Thyroid Clinical cases on RET/NTRK Lori Wirth, USA 006 14:05–14:25 Lung Clinical cases on RET/NTRK Noemi Reguart, Spain 007 14:25–14:30 Summary and close Lukas Bubendorf, Switzerland LS-08 Industry Symposium 13:00–14:30 Sydney Optimizing DNA Mismatch Repair (MMR) Analysis in Solid Tumors for Clinical Impact (Roche Diagnostics) Chair: Steven Stratton, USA 001 DNA Mismatch Repair Immunohistochemis- try in Solid Tumours Corrado D´Arrigo, United Kingdom 002 Molecular alternatives in MMR/MSI testing strategies Philippe Taniere, United Kingdom 003 Clinical impact of MMR/MSI testing in solid tumours Shobhit Baijal, United Kingdom LS-09 Industry Symposium 13:00–14:30 Montreal A Novel Approach to Targeting c-Met in NSCLC: Have Expectations Finally Been MET? (Abbvie) Chair: Ming Tsao, Canada 001 13:00–13:05 Welcome and Introductions Ming Tsao, Canada Industry Symposia